Nanocarriers for Targeted Therapy and Management of Liver Cancer

AvDevesh U. Kapoor,Bhupendra G. Prajapati

Häftad, Engelska, 2027

1 764 kr

Kommande

Beskrivning

Nanocarriers for Targeted Therapy and Management of Liver Cancer presents a comprehensive academic overview of nanocarrier-based strategies for addressing the biological, pharmacological, and translational challenges of liver cancer. The book positions nanomedicine as a critical enabler of targeted, safer, and more effective therapies for hepatocellular carcinoma and related malignancies. The volume systematically covers major nanocarrier platforms alongside emerging approaches such as AI-assisted design, pharmacokinetic modeling, nanotoxicology, clinical translation, and regulatory considerations. Each chapter integrates foundational concepts with current research, clinical trial insights, and future outlooks to ensure coherence and academic rigor. For researchers and graduate-level learners, the book provides an authoritative reference that bridges nanocarrier design, liver-specific biology, and translational feasibility. It supports advanced study, interdisciplinary research, and informed innovation in precision nanomedicine for liver cancer.

Integrates nanocarrier design principles with liver-specific tumor biology and translational challenges
Examines clinical trials, nanotoxicology, pharmacokinetics, and regulatory pathways alongside core technologies
Highlights emerging tools such as AI-assisted modeling, exosomes, and gene-based nanotherapeutics

Produktinformation

Utgivningsdatum:2027-03-01
Mått:191 x 235 x undefined mm
Vikt:450 g
Format:Häftad
Språk:Engelska
Antal sidor:270
Förlag:Elsevier Science
ISBN:9780443494628

Utforska kategorier

Biologi inom Naturvetenskap och teknik

Mer om författaren

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.

Innehållsförteckning

1. Introduction to Liver Cancer and Nanocarrier Based Therapeutics2. Liposomes as Nanocarriers for Liver Cancer Therapy3. Solid Lipid Nanoparticles for Liver Cancer4. Polymeric Nanoparticles for Liver Cancer Management5. Polymeric Micelles for Targeted Hepatic Delivery6. Dendrimers as Nanoscale Delivery Systems7. Mesoporous Silica Nanoparticles for Liver Cancer Therapy8. Metallic Nanoparticles in Liver Cancer Management9. Carbon Based Nanocarriers in Hepatic Oncology10. Hydrogel Based Nanocarriers for Localized Liver Cancer Therapy11. Exosomes and Biomimetic Nanocarriers12. Artificial Intelligence in Nanocarrier Design and Liver Cancer Management13. Clinical Translation, Nanotoxicology, and Trials of Nanocarriers14. Pharmacokinetics, Pharmacodynamics, and AI Assisted Modeling15. Regulatory Pathways, QbD, and Manufacturing Scale Up16. Gene and Nucleic Acid Based Nanocarrier Delivery Systems